Our top resource picks

GJE News
GJE announces alliance with Wächtershäuser & Hartz
GJE is pleased to announce that the firm has formed an alliance with the German patent and trade mark firm Wächtershäuser & Hartz (W&H)
Learn more
Article
Key considerations when patenting antibody-drug conjugates in Europe
Antibody-drug conjugates (ADCs) are a biotherapeutic modality typically used for the treatment of cancer.
Learn more-
GJE News
GJE announces alliance with Wächtershäuser & Hartz
GJE is pleased to announce that the firm has formed an alliance...
-
Article
Key considerations when patenting antibody-drug conjugates in Europe
Antibody-drug conjugates (ADCs) are a biotherapeutic modality typically used for the treatment...
-
Article
Supreme blow for Aldi in the battle of the copycats against Thatchers
On 12 June 2025, the Supreme Court refused permission for Aldi to...
-
Legal Update
G 1/23: EPO Enlarged Board of Appeal shines a light on non-reproducible prior art
The European Patent Office’s Enlarged Board of Appeal has issued its long-anticipated...
-
GJE News
GJE enters strategic partnership with Climate Connection
GJE is excited to announce that the firm has joined the climate...
All resources
Filters